British Journal of Cancer - Table of Contents alert Volume 106 Issue 11

TABLE OF CONTENTS Volume 106, Issue 11 (1713-1900) Published online 22 May 2012 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Letter to the Editor Also new today Advance online publication Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Hot off the press!! Did you know this article from British Journal of Cancer recently appeared in the press? Use of Aspirin postdiagnosis improves survival for colon cancer patients E Bastiaannet, K Sampieri et al. Read this Article now!   Minireview Top Tumour budding: a promising parameter in colorectal cancer A Lugli, E Karamitopoulou and I Zlobec Br J Cancer 2012 106: 1713-1717; advance online publication, April 24, 2012; 10.1038/bjc.2012.127 Abstract | Full Text Clinical Studies Top Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection A Dewdney, D Cunningham, Y Barbachano and I Chau Br J Cancer 2012 106: 1718-1721; advance online publication, April 24, 2012; 10.1038/bjc.2012.152 Abstract | Full Text Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study D Strumberg, M E Scheulen, B Schultheis, H Richly, A Frost, M Büchert, O Christensen, M Jeffers, R Heinig, O Boix and K Mross Br J Cancer 2012 106: 1722-1727; advance online publication, May 8, 2012; 10.1038/bjc.2012.153 Abstract | Full Text Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours S Kaye, S Aamdal, R Jones, G Freyer, E Pujade-Lauraine, E G E de Vries, J Barriuso, S Sandhu, D S-W Tan, V Hartog, B Kuenen, R Ruijter, G B Kristensen, M Nyakas, S Barrett, W Burke, D Pietersma, M Stuart, U Emeribe and E Boven Br J Cancer 2012 106: 1728-1734; advance online publication, April 24, 2012; 10.1038/bjc.2012.158 Abstract | Full Text Epithelial–mesenchymal transition biomarkers and support vector machine guided model in preoperatively predicting regional lymph node metastasis for rectal cancer X-J Fan, X-B Wan, Y Huang, H-M Cai, X-H Fu, Z-L Yang, D-K Chen, S-X Song, P-H Wu, Q Liu, L Wang and J-P Wang Br J Cancer 2012 106: 1735-1741; advance online publication, April 26, 2012; 10.1038/bjc.2012.82 Abstract | Full Text Therapy of chronic myeloid leukaemia can benefit from the activation of stem cells: simulation studies of different treatment combinations I Glauche, K Horn, M Horn, L Thielecke, M AG Essers, A Trumpp and I Roeder Br J Cancer 2012 106: 1742-1752; advance online publication, April 26, 2012; 10.1038/bjc.2012.142 Abstract | Full Text Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study A Patel, K Galaal, C Burnley, K Faulkner, P Martin-Hirsch, M J Bland, S Leeson, H Beer, S Paranjothy, P Sasieni and R Naik Br J Cancer 2012 106: 1753-1759; advance online publication, April 24, 2012; 10.1038/bjc.2012.148 Abstract | Full Text Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer S Barton, L Zabaglo, R A'Hern, N Turner, T Ferguson, S O'Neill, M Hills, I Smith and M Dowsett Br J Cancer 2012 106: 1760-1765; advance online publication, April 24, 2012; 10.1038/bjc.2012.166 Abstract | Full Text Translational Therapeutics Top Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial J Cummings, M Zweifel, N Smith, P Ross, J Peters, G Rustin, P Price, M R Middleton, T Ward and C Dive Br J Cancer 2012 106: 1766-1771; advance online publication, April 26, 2012; 10.1038/bjc.2012.165 Abstract | Full Text Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells J Wang, T P Hughes, C H Kok, V A Saunders, A Frede, K Groot-Obbink, M Osborn, A A Somogyi, R J D'Andrea and D L White Br J Cancer 2012 106: 1772-1778; advance online publication, April 24, 2012; 10.1038/bjc.2012.173 Abstract | Full Text Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer A H Sims, A JM Zweemer, Y Nagumo, D Faratian, M Muir, M Dodds, I Um, C Kay, M Hasmann, D J Harrison and S P Langdon Br J Cancer 2012 106: 1779-1789; advance online publication, May 1, 2012; 10.1038/bjc.2012.176 Abstract | Full Text Molecular Diagnostics Top Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients R E Payne, F Wang, N Su, J Krell, A Zebrowski, E Yagüe, X-J Ma, Y Luo and R C Coombes Br J Cancer 2012 106: 1790-1797; advance online publication, April 26, 2012; 10.1038/bjc.2012.137 Abstract | Full Text Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer H R Ali, S-J Dawson, F M Blows, E Provenzano, P D Pharoah and C Caldas Br J Cancer 2012 106: 1798-1806; advance online publication, April 26, 2012; 10.1038/bjc.2012.167 Abstract | Full Text Quiescence and γH2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase H Hiyoshi, S Abdelhady, L Segerström, B Sveinbjörnsson, M Nuriya, T K Lundgren, L Desfrere, A Miyakawa, M Yasui, P Kogner, J I Johnsen, M Andäng and P Uhlén Br J Cancer 2012 106: 1807-1815; advance online publication, April 24, 2012; 10.1038/bjc.2012.159 Abstract | Full Text Development of robust discriminant equations for assessing subtypes of glioblastoma biopsies X Castells, J J Acebes, C Majós, S Boluda, M Julià-Sapé, A P Candiota, J Ariño, A Barceló and C Arús Br J Cancer 2012 106: 1816-1825; advance online publication, May 8, 2012; 10.1038/bjc.2012.174 Abstract | Full Text Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer M Pichler, E Winter, M Stotz, K Eberhard, H Samonigg, S Lax and G Hoefler Br J Cancer 2012 106: 1826-1832; advance online publication, May 1, 2012; 10.1038/bjc.2012.175 Abstract | Full Text Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis Y S Lee, I Choi, Y Ning, N Y Kim, V Khatchadourian, D Yang, H K Chung, D Choi, M J LaBonte, R D Ladner, K C Nagulapalli Venkata, D O Rosenberg, N A Petasis, H-J Lenz and Y-K Hong Br J Cancer 2012 106: 1833-1841; 10.1038/bjc.2012.177 Abstract | Full Text Epidemiology Top Impact of mental health problems on case fatality in male cancer patients G D Batty, E Whitley, C R Gale, D Osborn, P Tynelius and F Rasmussen Br J Cancer 2012 106: 1842-1845; advance online publication, April 19, 2012; 10.1038/bjc.2012.150 Abstract | Full Text Avoidable deaths and random variation in patients' survival K Seppä, T Hakulinen and E Läärä Br J Cancer 2012 106: 1846-1849; advance online publication, April 24, 2012; 10.1038/bjc.2012.169 Abstract | Full Text Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden G Frisk, T Svensson, L M Bäcklund, E Lidbrink, P Blomqvist and K E Smedby Br J Cancer 2012 106: 1850-1853; advance online publication, April 24, 2012; 10.1038/bjc.2012.163 Abstract | Full Text Should relative survival be used with lung cancer data? S R Hinchliffe, M J Rutherford, M J Crowther, C P Nelson and P C Lambert Br J Cancer 2012 106: 1854-1859; advance online publication, May 3, 2012; 10.1038/bjc.2012.182 Abstract | Full Text Evaluation of prevalent and incident ovarian cancer co-morbidity K Stålberg, T Svensson, F Granath, H Kieler, B Tholander and S Lönn Br J Cancer 2012 106: 1860-1865; advance online publication, May 1, 2012; 10.1038/bjc.2012.164 Abstract | Full Text Inflammation marker and risk of pancreatic cancer: a nested case–control study within the EPIC cohort V A Grote, R Kaaks, A Nieters, A Tjønneland, J Halkjær, K Overvad, M R Skjelbo Nielsen, M C Boutron-Ruault, F Clavel-Chapelon, A Racine, B Teucher, S Becker, T Pischon, H Boeing, A Trichopoulou, C Cassapa, V Stratigakou, D Palli, V Krogh, R Tumino, P Vineis, S Panico, L Rodríguez, E J Duell, M-J Sánchez, M Dorronsoro, C Navarro, A B Gurrea, P D Siersema, P HM Peeters, W Ye, M Sund, B Lindkvist, D Johansen, K-T Khaw, N Wareham, N E Allen, R C Travis, V Fedirko, M Jenab, D S Michaud, S-C Chuang, D Romaguera, H B Bueno-de-Mesquita and S Rohrmann Br J Cancer 2012 106: 1866-1874; advance online publication, April 26, 2012; 10.1038/bjc.2012.172 Abstract | Full Text Survival from colorectal cancer in Germany in the early 21st century O Majek, A Gondos, L Jansen, K Emrich, B Holleczek, A Katalinic, A Nennecke, A Eberle, H Brenner and the GEKID Cancer Survival Working Group Br J Cancer 2012 106: 1875-1880; advance online publication, May 3, 2012; 10.1038/bjc.2012.189 Abstract | Full Text Alcohol intake and renal cell cancer risk: a meta-analysis D Y Song, S Song, Y Song and J E Lee Br J Cancer 2012 106: 1881-1890; advance online publication, April 19, 2012; 10.1038/bjc.2012.136 Abstract | Full Text Dietary intake of meat, fruits, vegetables, and selective micronutrients and risk of bladder cancer in the New England region of the United States J W Wu, A J Cross, D Baris, M H Ward, M R Karagas, A Johnson, M Schwenn, S Cherala, J S Colt, K P Cantor, N Rothman, D T Silverman and R Sinha Br J Cancer 2012 106: 1891-1898; advance online publication, May 8, 2012; 10.1038/bjc.2012.187 Abstract | Full Text Letter to the Editor Top Comment on ‘Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection’ A Bearz, E Vaccher, R Talamini, M Berretta and U Tirelli Br J Cancer 2012 106: 1899-1900; advance online publication, May 3, 2012; 10.1038/bjc.2012.181 Full Text Advertisement British Journal of Cancer presents: Web Focus on MicroRNA MicroRNAs have emerged as major new mechanisms of regulation of gene function, potential therapeutic targets, with roles in diagnosis, prognosis and biomarkers. This collection puts MicroRNA in context of other molecular classifications and then investigative articles and reviews cover the main tumour types where microRNAs are emerging as having important roles in biological processes including lung cancer, AML, melanoma, colorectal cancer, nasopharyngeal carcinoma, bladder cancer, rhabdomyosarcoma and heptacellular carcinoma. Read the articles for FREE   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.